🔎 Trials Near Me

Home › Leukemia › California › Los Angeles

Leukemia clinical trials in Los Angeles, CA

17 studies for Leukemia are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RecruitingPhase 3
  • Cedars-Sinai Medical Center, Los Angeles
  • USC Norris Cancer Center, Los Angeles
  • University of California, Los Angeles, Los Angeles
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07007312

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

RecruitingObservational studyHealthy volunteers welcome
  • Children s Hospital of Los Angeles, Los Angeles
Ages 5 and older · All sexes · Updated Nov 9, 2026 · NCT05237986

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

RecruitingPhase 3
  • USC Norris Comprehensive Cancer Center, Los Angeles
Ages 18 to 71 · All sexes · Updated Oct 30, 2026 · NCT07504458

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

RecruitingPhase 1/2
  • Valkyrie Clinical Trials, Los Angeles
Ages 13 to 90 · All sexes · Updated Oct 26, 2026 · NCT06533579

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

RecruitingObservational study
  • Children's Hospital Los Angeles, Los Angeles
  • Cedars Sinai Medical Center, Los Angeles
  • Mattel Children's Hospital UCLA, Los Angeles
All ages · All sexes · Updated Oct 20, 2026 · NCT00736749

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

RecruitingPhase 1/2
  • Research Site, Los Angeles
Ages 12 and older · All sexes · Updated Oct 13, 2026 · NCT06137118

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

RecruitingPhase 2/3
  • Keck School of Medicine of USC, Los Angeles
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT04256317

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

RecruitingPhase 2
  • USC Norris Comprehensive Cancer Center, Los Angeles
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06824168

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

RecruitingPhase 2
  • UCLA Medical Center, Los Angeles
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04996875

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

RecruitingPhase 1
  • USC Norris Comprehensive Cancer Center, Los Angeles
  • UCLA Health - Bowyer Oncology Center, Los Angeles
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06001788

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

RecruitingPhase 2
  • Children's Hospital Los Angeles, Los Angeles
Ages 7 to 25 · All sexes · Updated Aug 19, 2026 · NCT05082519

Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

RecruitingPhase 1/2
  • David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles
Ages 18 and older · All sexes · Updated Jul 17, 2026 · NCT06810778

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

RecruitingPhase 2
  • UCLA Department of Medicine, Los Angeles
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT07216443

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

RecruitingPhase 1/2
  • Los Angeles Cancer Network, Los Angeles
  • UCLA Medical Center of Hematology/Oncology, Los Angeles
Ages 12 to 95 · All sexes · Updated Apr 15, 2026 · NCT04329728

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RecruitingPhase 1
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • UCLA - Bowyer Oncology Center, Los Angeles
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT05735184

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

RecruitingPhase 1
  • University of California Los Angeles, Los Angeles
Ages 18 and older · All sexes · Updated Sep 24, 2025 · NCT06501196

Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.

RecruitingHealthy volunteers welcome
  • Children's Hospital Los Angeles, Los Angeles
Ages 3 and older · All sexes · Updated Aug 3, 2025 · NCT06360718

About Leukemia

Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.

More about Leukemia on MedlinePlus

Leukemia trials in other cities

Other studies in Los Angeles

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.